Shaant Spot Hero Drying Acne Treatment Gel
NDC Package 83196-690-12
Package Information
Shaant Spot Hero Drying Acne Treatment (sulfur) gel is clean the skin thoroughly before applying this product cover the entire affected area with a thin layer 1 to 3 times daily because excessive drying of the skin may occur, start with 1 application daily, then gradually increase to 2 or 3 times daily if needed or as directed by a doctor if bothersome dryness or peeling occurs, reduce application to once a day or every other day. This formulation utilizes a gel delivery system. Marketed by Codex Labs Corporation, this product is identified by NDC 83196-690 and is authorized under FDA application M006.
Identification & Billing
- RxCUI: 283392 - sulfur 5 % Topical Gel
- RxCUI: 283392 - sulfur 0.05 MG/MG Topical Gel
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 83196 - Codex Labs Corporation
- 83196-690 - Shaant Spot Hero Drying Acne Treatment
- 83196-690-12 - 1 TUBE in 1 CARTON / 15 mL in 1 TUBE
- 83196-690 - Shaant Spot Hero Drying Acne Treatment
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 83196-690-12 identifies a specific commercial package of 1 tube in 1 carton / 15 ml in 1 tube of Shaant Spot Hero Drying Acne Treatment, a human over the counter drug labeled by Codex Labs Corporation. This gel is formulated for topical use and contains sulfur as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Codex Labs Corporation on May 15, 2023. The current certification is valid through December 31, 2026.
How is this Codex Labs Corporation product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 83196069012. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.